Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with advanced pancreatic ductal adenocarcinoma (PDA).

The combination of HBI-8000 and nivolumab induced a response in nearly two-thirds of patients with advanced melanoma and no ...

Greeny, A, Nair, A, Sadanandan, P, Satarker, S, Famurewa, AC and Nampoothiri, M (2024) Epigenetic Alterations in Alzheimer's ...

As with other disease states, biomarkers that can provide value across diagnosis, prognosis, and treatment response, have ...

Result of General Meeting (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing ...

After hours: November 29 at 4:18 PM EST Loading Chart for VNDA ...

In this potentially valuable study, the authors employed in vivo experiments and theoretical modeling to study the growth dynamics of nuclear condensates. They observed that condensates can exhibit ...

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.